K-numberK253230
Device nameERBECRYO 2 Cryosurgical Unit and Accessories: ERBECRYO 2 cryosurgical unit; Erbe Flexible Cryoprobe
ApplicantErbe Elektromedizin GmbH
Product codeGEH
Device classClass II
Decision dateApr 22, 2026
DecisionSubstantially Equivalent
Regulation878.4350
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The ERBECRYO 2 is a cryosurgical unit that delivers regulated CO₂ gas to flexible cryoprobes to destroy tissue through extreme cold (Joule-Thomson effect). The new Erbe Flexible Cryoprobes are sterile, single-use probes intended for palliative devitalization and removal of foreign bodies, blood clots, tumors, and tissue biopsies during interventional procedures, particularly in the gastrointestinal tract.

Technological characteristics

The subject device adds an elongated variant of the flexible cryoprobe with increased distal length (2550 mm vs. 1150 mm in predicate), outer diameter of 1.7 mm, and same input pressure range (769–943 psi). All other characteristics—materials (stainless steel, silicone, plastics), operating principle (CO₂ cooling), energy delivery, sterilization method (ethylene oxide), and shelf-life (3 years)—are identical to the predicate device.

Test standards cited

ISO 13485 (design controls), ISO 14971 (risk analysis), ISO 11135 (sterilization validation), ISO 10993-1 and ISO 10993-7 (biocompatibility and EO residuals), ISO 11607-1 (packaging), ASTM F 1980 (shelf-life aging), IEC 60601-1-2 (electromagnetic compatibility), IEC 60601-1 (electrical safety), and IEC 62304 (software verification).

Substantial equivalence argument

The subject device is substantially equivalent because it has identical intended use, the same fundamental design and energy source, and equivalent freezing performance as demonstrated by side-by-side tissue testing. The only difference—increased probe length—poses no new safety or effectiveness questions and actually provides improved benefits (better reach in the GI tract) while maintaining the same risk profile, supported by peer-reviewed literature and a randomized controlled trial.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →